Selective NNMT Inhibitor
A small-molecule selective inhibitor of NNMT, an enzyme that consumes methyl groups from S-adenosyl-methionine (SAM) and depletes the NAD+ precursor nicotinamide. Investigated as a research tool for studying methyl-donor balance and adipocyte metabolism in preclinical models.
In published preclinical literature, 5-Amino-1MQ has been administered orally or via intraperitoneal injection in rodent models, with dosing typically scaled by body weight in mg/kg ranges.
The metabolic-research community has shown sustained interest in 5-Amino-1MQ because NNMT inhibition sits at the intersection of two highly studied pathways — methyl-donor metabolism and NAD+ biology. Investigators have explored its activity in adipose-tissue models, muscle-cell energetics, and nutrient-sensing networks, often in parallel with other NAD+-pathway research compounds.
For research purposes only. Not intended for consumption, clinical application, or diagnostic use.